logo 600X600.png
Global Dementia Drugs Market to Surpass US$ 39,663.6 Million by 2030, Says Coherent Market Insights (CMI)
26 juil. 2022 08h40 HE | CMI
Seattle, July 26, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global dementia drugs market is estimated to be valued at US$ 20,677.0 million in 2022 and is expected to...
Future Market Insights.png
Alzheimer’s Therapeutics Market Is Set to Expand at a CAGR Of 9.3% To reach US$ 6.8 Bn By The Year 2032 : FMI DUBAI, United Arab Emirates, April 15, 2022 (GLOBE NEWSWIRE) -- Alzheimer’s Therapeutics is the most common reason for progressive dementia in the elderly population. There has been an exponential...
Fior-Markets-Logo.jpg
Global Alzheimer’s Therapeutics Market is Expected to Reach USD 8.19 Billion By 2026 : Fior Markets
09 juil. 2019 07h57 HE | Fior Markets
New Jersey, NJ, July 09, 2019 (GLOBE NEWSWIRE) -- Fior Markets launched a study titled "Alzheimer’s Therapeutics Market by Drug Type (Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor...
RND logo.PNG
Alzheimer’s Therapeutics Market to Reach USD 12.43 Billion By 2026 | Reports And Data
02 mai 2019 12h00 HE | Reports And Data
Rising incidence of investment in biomarkers for drug development is the major factor influencing market growth. Market Size – USD 18.23 billion in 2018, Market Growth - CAGR of 4.6%, Market Trends...